Excessive chronic IL-6 production promotes the development of insulin resistance and T2D by impairing the phosphorylation of IR and IRS-1 via the upregulation of SOCS-3 (suppressor of cytokine signaling 3) [185], a potential inhibitor of insulin signaling [186]. The gene discussed is IRS1; the disease is Insulin resistance.